Nakamoto Internal Medicine Clinic

The trials here

What the 3 trials at this site are about, from their registry records.

Conditions

• Type 2 diabetes3 trials

Phase

• Phase 33 trials

Status

• Completed3 trials

Lead sponsor

• Eli Lilly and Company3 trials

Closed trials

• Completed

  A Long-term Safety Study of Orforglipron (LY3502970) in Participants With Type 2 Diabetes

  NCT06010004· Phase 3· Eli Lilly and Company· Source

• Completed

  A Study of Orforglipron (LY3502970) Compared With Semaglutide in Participants With Type 2 Diabetes Inadequately Controlled With Metformin

  NCT06045221· Phase 3· Eli Lilly and Company· Source

• Completed

  A Study of Insulin Efsitora Alfa (LY3209590) Compared With Insulin Degludec in Participants With Type 2 Diabetes Currently Treated With Basal Insulin

  NCT05275400· Phase 3· Eli Lilly and Company· Source